Phase 3 clinical trial of a combination of MGV-5 and AS-4370 as pretreatment for barium enema X-ray radiography
Phase 3
- Conditions
- Examinees who undergo barium enema X-ray radiography
- Registration Number
- JPRN-jRCT2080220422
- Lead Sponsor
- Ajinomoto Pharmaceuticals Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Major inclusion criteria:
Persons aged >=20 and <75 years scheduled to undergo Barium enema X-ray examination.
Major exclusion criteria:
Persons who have or are suspected of having gastrointestinal obstruction or intestinal obstruction.
Persons who have intestinal perforation.
Persons who have toxic megacolon.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score for barium adhesion and fecal residue amount
- Secondary Outcome Measures
Name Time Method